Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,240 | 301 | 96.6% |
| Education | $221.94 | 6 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,032 | 66 | $0 (2024) |
| Amgen Inc. | $1,025 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $881.18 | 58 | $0 (2024) |
| Inari Medical, Inc. | $508.76 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $429.26 | 24 | $0 (2024) |
| Boston Scientific Corporation | $416.73 | 18 | $0 (2023) |
| Abbott Laboratories | $395.65 | 12 | $0 (2024) |
| PFIZER INC. | $328.67 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $266.88 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $199.94 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,004 | 21 | Amgen Inc. ($243.36) |
| 2023 | $1,201 | 42 | Inari Medical, Inc. ($289.89) |
| 2022 | $1,348 | 70 | Amgen Inc. ($222.78) |
| 2021 | $1,067 | 47 | Novartis Pharmaceuticals Corporation ($220.61) |
| 2020 | $259.02 | 16 | Janssen Pharmaceuticals, Inc ($75.89) |
| 2019 | $463.56 | 34 | Novartis Pharmaceuticals Corporation ($177.06) |
| 2018 | $503.85 | 36 | Janssen Pharmaceuticals, Inc ($153.11) |
| 2017 | $615.22 | 41 | Janssen Pharmaceuticals, Inc ($149.56) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $45.68 | General |
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $27.10 | General |
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $73.17 | General |
| 07/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $145.88 | General |
| Category: Heart Failure | ||||||
| 06/17/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Lithoplasty | ||||||
| 06/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $15.35 | General |
| 03/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $82.06 | General |
| Category: Cardiology | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $49.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $35.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/12/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $172.81 | General |
| Category: VTE | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $117.97 | General |
| Category: Rare Disease | ||||||
| 01/18/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $38.87 | General |
| Category: Medical Device | ||||||
| 01/12/2024 | Biosense Webster, Inc. | CARTO 3 (Device), QDOT MICRO Catheter | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Cardiology | ||||||
| 11/30/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $44.87 | General |
| Category: VTE | ||||||
| 11/29/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $85.66 | General |
| Category: Cardiology | ||||||
| 11/09/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: VTE | ||||||
| 10/20/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: VTE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,832 | 2,125 | $566,895 | $99,134 |
| 2022 | 22 | 1,513 | 1,718 | $513,282 | $90,098 |
| 2021 | 27 | 1,825 | 2,203 | $519,977 | $113,799 |
| 2020 | 31 | 2,195 | 2,482 | $637,368 | $126,724 |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 195 | 286 | $36,196 | $18,768 | 51.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 243 | 251 | $190,773 | $13,124 | 6.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 157 | $34,959 | $9,753 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 122 | 148 | $12,233 | $7,259 | 59.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 55 | $33,307 | $7,218 | 21.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 35 | 36 | $43,047 | $6,952 | 16.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 12 | 14 | $23,166 | $5,760 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 72 | $20,892 | $5,758 | 27.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 94 | 95 | $16,720 | $5,308 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 29 | 29 | $6,242 | $2,771 | 44.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 28 | 28 | $33,455 | $2,207 | 6.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 26 | 26 | $19,599 | $1,868 | 9.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 221 | 242 | $7,424 | $1,365 | 18.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 44 | 45 | $4,138 | $1,326 | 32.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 45 | 45 | $3,636 | $1,176 | 32.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 71 | 71 | $6,490 | $1,068 | 16.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 101 | 102 | $6,494 | $1,053 | 16.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 50 | 50 | $3,057 | $840.50 | 27.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 21 | $3,430 | $821.94 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,364 | $801.90 | 23.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 71 | 71 | $5,757 | $637.44 | 11.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 21 | 21 | $1,876 | $616.35 | 32.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 30 | 31 | $12,394 | $581.40 | 4.7% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 16 | 20 | $1,682 | $461.44 | 27.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 43 | $6,343 | $370.57 | 5.8% |
About Dr. Mohan Madala, MD
Dr. Mohan Madala, MD is a Cardiovascular Disease healthcare provider based in Okemos, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295949030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Madala, MD has received a total of $6,462 in payments from pharmaceutical and medical device companies, with $1,004 received in 2024. These payments were reported across 307 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,240).
As a Medicare-enrolled provider, Madala has provided services to 7,365 Medicare beneficiaries, totaling 8,528 services with total Medicare billing of $429,755. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Okemos, MI
- Active Since 05/10/2007
- Last Updated 06/13/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295949030
Products in Payments
- ENTRESTO (Drug) $890.00
- XARELTO (Drug) $874.21
- Repatha (Biological) $643.88
- FLOWTRIEVER CATHETER, S (Device) $493.59
- ELIQUIS (Drug) $404.02
- Corlanor (Drug) $199.61
- CAMZYOS (Drug) $193.35
- WATCHMAN Access System (Device) $175.32
- CARDIOMEMS (Device) $145.88
- LEQVIO (Drug) $141.75
- VYNDAQEL (Drug) $129.98
- Optimizer Smart System (Device) $122.37
- ANDEXXA (Biological) $117.97
- Adempas (Drug) $75.52
- BRILINTA (Drug) $66.87
- (5044) MCOT (Device) $64.68
- WATCHMAN (Device) $64.57
- JARDIANCE (Drug) $62.79
- OPSUMIT (Drug) $61.14
- IGT_D Therapy (Device) $54.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Okemos
Eugene Choo, Md, MD
Cardiovascular Disease — Payments: $8,519
Michael Grimm, Md, MD
Cardiovascular Disease — Payments: $7,771
Omar Bakr, M.d, M.D
Cardiovascular Disease — Payments: $5,534
Dr. Paul Zack, M.d, M.D
Cardiovascular Disease — Payments: $1,254